Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

NCT04337970 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Kidney Cancer
Renal Cell Carcinoma
Unresectable Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma

Interventions

DRUG: Talazoparib
DRUG: Axitinib

Sponsor

Memorial Sloan Kettering Cancer Center